Sales of Jan Aushadhi outlets reached Rs 1,000 crore mark in October this year, a feat that was achieved in December 2023.
Notably, Pharmaceuticals & Medical Devices Bureau of India (PMBI) had sold medicines worth Rs 200 crore in single month of September 2024.
"This achievement highlights the growing trust and reliance of the people on affordable and quality medicines. This was possible only with the unwavering support of the citizens, who have embraced the initiative by purchasing medicines from over 14,000 Jan Aushadhi Kendras across the country," Ministry of Chemicals and Fertilisers said in a statement.
The substantial growth is a testament to PMBI's commitment to making healthcare accessible and affordable for all by reducing out of pocket expenditure, it added.
In the last 10 years, there has been a growth of more than 170 times in number of Jan Aushadhi outlets in the country.
From 80 outlets in 2014, the number has increased to more than 14,000 outlets now, covering almost all the districts of the country.
Over the next two years, the government is targeting to have around 25,000 Jan Aushadhi Kendras in the country.
The product basket of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) comprises 2,047 medicines and 300 surgical devices covering all major therapeutic groups.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)